The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
N.m.r. and molecular-modelling studies of the solution conformation of heparin
Open accessAbstract
The solution conformations of heparin and de-N-sulphated, re-N-acetylated heparin have been determined by a combination of n.m.r. spectroscopic and molecular-modelling techniques. The 1H- and 13C-n.m.r. spectra of these polysaccharides have been assigned. Observed 1H-1H nuclear Overhauser enhancements (n.O.e.s) have been simulated using the program NOEMOL [Forster, Jones and Mulloy (1989) J. Mol. Graph. 7, 196-201] for molecular models derived from conformational-energy calculations; correlation times for the simulations were chosen to fit experimentally determined 13C spin-lattice relaxation times. In order to achieve good agreement between calculated and observed 1H-1H n.O.e.s it was necessary to assume that the reorientational motion of the polysaccharide molecules was not isotropic, but was that of a symmetric top. The resulting model of heparin in solution is similar to that determined in the fibrous state by X-ray-diffraction techniques [Nieduszynski, Gardner and Atkins (1977) Am. Chem. Soc. Symp. Ser. 48, 73-80].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991) · Science · doi:10.1126/science.1646484 · Cited by 1,508
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences
Ferro, D. R., Provasoli, A., Ragazzi, M., Casu, B., Torri, G., Bossennec, V., Perly, B., Sinaÿ, P., Petitou, M., & Choay, J. (1990) · Carbohydrate Research · doi:10.1016/0008-6215(90)84164-p · Cited by 241
Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides
Folkman, J., & Shing, Y. (1992) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-2444-5_34 · Cited by 224
Damon, D. H., Lobb, R. R., D'Amore, P. A., & Wagner, J. A. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380202 · Cited by 182
Conformational equilibria of α-L-iduronate residues in disaccharides derived from heparin
Sanderson, P. N., Huckerby, T. N., & Nieduszynski, I. A. (1987) · Biochemical Journal · doi:10.1042/bj2430175 · Cited by 91
Tones, M. A., Bootman, M. D., Higgins, B. F., Lane, D. A., Pay, G. F., & Lindahl, U. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80898-1 · Cited by 70
[28] Molecular design and modeling of protein—heparin interactions
Cardin, A. D., Demeter, D. A., Weintraub, H. J. R., & Jackson, R. L. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)03030-k · Cited by 61
Cited by
Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., & Mohammadi, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00073-3 · Cited by 1,199
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Heparin and heparan sulfate: Structure and function
Rabenstein, D. L. (2002) · Natural Product Reports · doi:10.1039/b100916h · Cited by 870
3D printing of hydrogels: Rational design strategies and emerging biomedical applications
Li, J., Wu, C., Chu, P. K., & Gelinsky, M. (2020) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2020.100543 · Cited by 862
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., & Blundell, T. L. (2000) · Nature · doi:10.1038/35039551 · Cited by 704
Self-citation2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity
Linhardt, R. J. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030176m · Cited by 493
Structural Insights into Biological Roles of Protein-Glycosaminoglycan Interactions
Raman, R., Sasisekharan, V., & Sasisekharan, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.020 · Cited by 434
Enzymatic Degradation of GlycosaminogIycans
Ernst, S., Langer, R., Cooney, C. L., & Sasisekharan, R. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083490 · Cited by 387
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380
Structure and biological interactions of heparin and heparan sulfate
Casu, B., & Lindahl, U. (2001) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/s0065-2318(01)57017-1 · Cited by 375
Structure of a heparin-linked biologically active dimer of fibroblast growth factor
DiGabriele, A. D., Lax, I., Chen, D. I., Svahn, C. M., Jaye, M., Schlessinger, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31741 · Cited by 353
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 341
Self-citationHeparin and heparan sulfate: biosynthesis, structure and function
Sasisekharan, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00145-9 · Cited by 326
Heparan sulfate: growth control with a restricted sequence menu
Gallagher, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13713 · Cited by 319
Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal Extension
Coles, C. H., Shen, Y., Tenney, A. P., Siebold, C., Sutton, G. C., Lu, W., Gallagher, J. T., Jones, E. Y., Flanagan, J. G., & Aricescu, A. R. (2011) · Science · doi:10.1126/science.1200840 · Cited by 319
Conformation and dynamics of heparin and heparan sulfate
Mulloy, B., & Forster, M. J. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1147 · Cited by 315
Self-citationStructural basis for sialic acid–mediated self-recognition by complement factor H
Blaum, B. S., Hannan, J. P., Herbert, A. P., Kavanagh, D., Uhrín, D., & Stehle, T. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1696 · Cited by 278
Defining the Interleukin-8-binding Domain of Heparan Sulfate
Spillmann, D., Witt, D., & Lindahl, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15487 · Cited by 273
Structural diversity of heparan sulfate binding domains in chemokines
Lortat-Jacob, H., Grosdidier, A., & Imberty, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032497699 · Cited by 259
Crystal structure of the TSP-1 type 1 repeats
Tan, K., Duquette, M., Liu, J.-H., Dong, Y., Zhang, R., Joachimiak, A., Lawler, J., & Wang, J.-H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200206062 · Cited by 258
Powell, A. K. (2004) · Glycobiology · doi:10.1093/glycob/cwh051 · Cited by 257
Structural basis for complement factor H linked age-related macular degeneration
Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrín, D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071069 · Cited by 184
New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E
Libeu, C. P., Lund-Katz, S., Phillips, M. C., Wehrli, S., Hernáiz, M. J., Capila, I., Linhardt, R. J., Raffaı̈, R. L., Newhouse, Y. M., Zhou, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104746200 · Cited by 113
Interaction of the N-Terminal Domain of Apolipoprotein E4 with Heparin
Dong, J., Peters-Libeu, C. A., Weisgraber, K. H., Segelke, B. W., Rupp, B., Capila, I., Hernáiz, M. J., LeBrun, L. A., & Linhardt, R. J. (2001) · Biochemistry · doi:10.1021/bi002417n · Cited by 99
Parthasarathy, N., Goldberg, I. J., Sivaram, P., Mulloy, B., Flory, D. M., & Wagner, W. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31802-1 · Cited by 90
Self-citationHigh sulfation and a high molecular weight are important for anti-hepcidin activity of heparin
Asperti, M., Naggi, A., Esposito, E., Ruzzenenti, P., Di Somma, M., Gryzik, M., Arosio, P., & Poli, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00316 · Cited by 17
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Metadata
- Authors
- Mulloy, B., Forster, M. J., Jones, C., & Davies, D. B.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1993-08-01
- Volume
- 293
- Issue
- 3
- Pages
- 849-858
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1877090369
- Cited by
- 410
- References
- 12
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.